The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Baeva N.G.

Rodil'nyĭ dom #26, zhenskaia konsul'tatsiia, Moskva

Filiaeva Yu.A.

Maternity House No. 26, Women's Consultation, Moscow

The comparative analysis of effectiveness of Dienogest and Leuprorelin in the complex treatment of genital endometriosis

Authors:

Baeva N.G., Filiaeva Yu.A.

More about the authors

Read: 8149 times


To cite this article:

Baeva NG, Filiaeva YuA. The comparative analysis of effectiveness of Dienogest and Leuprorelin in the complex treatment of genital endometriosis. Russian Journal of Human Reproduction. 2013;(4):39‑43. (In Russ.)

Recommended articles:

References:

  1. Schindler A.E. Levonorgestrelvysvobozhdayushchaya vnutrimatochnaya sistema v lechenii i profilaktike ginekologicheskikh zabolevanii. Ginekologiya 2006; 3-5 (spetsvypusk).
  2. Andersson K., Rybo G. Levonorgestrel-releasing intrauterine device in the treatment of menorrhagia. Br J Obstet Gynecol 1990; 97: 690-694.
  3. Bhattacharya et al. Cooper and the International Heavy Menstrual Bleeding Individual Patient Data Metaanalysis Collaborative Group Hysterectomy, endometrial ablation and Mirena® for heavy menstrual bleeding: a systematic review of clinical effectiveness and cost-effectiveness analysis; Health Technol Ass 2011; 15: 19.
  4. Nelson A. Levonorgestrel intrauterine: a first-line medical treatment for heavy menstrual bleeding. Women's Health 2010; 6: 3: 347-356.
  5. Pakarinen P., Toivonen J., Luukainen T. Seminars in Reproductive Medicine 2001, 19 (4). Terapevticheskie aspekty ispol'zovaniya levonorgestrelsoderzhashchei sistemy "Mirena" i konsul'tirovanie patsientok. Ginekologiya 2003; 5: 1: 4-9.
  6. Andreeva E.N. Farmakoekonomicheskaya otsenka ispol'zovaniya razlichnykh metodov lecheniya menorragii. Probl reprod 2011; 4: 48-54.
  7. Mezhevitinova E.A. Progestageny v kontratseptsii. Ginekologiya 2001; 3: 2: 36-38.
  8. Mezhevitinova E.A. Fertil'nost' posle prekrashcheniya kontratseptsii. Ginekologiya 2012; 14: 2: 48-51.
  9. Natsional'nye meditsinskie kriterii priemlemosti metodov kontratseptsii, 2012; 12 (rabochii variant).
  10. Prilepskaya V.N. Gormonal'naya kontratseptsiya i gormonal'naya terapiya - zven'ya odnoi tsepi. Ginekologiya 2006; 6-10 (spetsvypusk).
  11. Ostreikova L.I. Gormonal'naya vnutrimatochnaya levonorgestrel-rilizing-sistema (obzor literatury). Ginekologiya 2003; 5: 4: 138-144.
  12. Prilepskaya V.N., Mezhevitinova E.A. Gormonal'naya kontratseptsiya. M 2011; 156-158.
  13. Prilepskaya V.N., Letunovskaya A.B. Menorragii i vnutrimatochnaya gormonal'naya rilizing-sistema. Ginekologiya 2011; 13: 5: 2-4.
  14. Radzinskii V.E. Akusherskaya agressiya. M: Mediabyuro Status prezens 2011; 688.
  15. Rogovskaya S.I. Vnutrimatochnaya gormonal'naya rilizing-sistema: kontratseptivnye i lechebnye svoistva. Pod red. V.N. Prilepskoi. Klin ginekol 2007; 212-217.
  16. Savel'eva I.S. Illyuziya bezopasnosti. Status Praesens 2011; 3: 6: 81-85.
  17. Savel'eva I.S., Gorodnicheva Zh.A. Rasshirenie ispol'zovaniya vnutrimatochnoi sistemy Mirena: kriterii priemlemosti VOZ. Trudnyi patsient 2007; 5: 1: 3-9.
  18. Talibov O.B. Dokazatel'naya meditsina v ginekologii. M: Baier 2011; 1, 10.
  19. Shipova V.M., Vorob'ev S.V. Farmakoekonomicheskaya otsenka effektivnosti lecheniya. Zdravookhranenie 2006; 1: 19-25.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.